Jeffery N. Wilkins, MD is Vice Chair of the Department of Psychiatry at Cedars-Sinai. Dr. Wilkins is also Medical Director of Addiction Medicine and Director of Addiction Studies within the department's Clinical Trials Unit. In addition, he is the Program Director for the ACGME-approved Fellowship in Addiction Psychiatry. He holds the Lincy Foundation/Andrew Heyward-Amy Moynihan Chair in Addiction Medicine.
Dr. Wilkins' research interests include pharmacotherapy of patients with substance abuse problems and/or mental illness, the pharmacokinetics of abused substances and the identification of biological markers for psychiatric disorders. His investigations have received funding from the National Institute on Drug Abuse, the National Institute of Mental Health and the Veterans Administration. Dr. Wilkins is also evaluating innovating techniques in substance abuse prevention in adolescents and children, including the use of health-oriented video games.
A board-certified psychiatrist, Dr. Wilkins is a diplomate of the American Board of Medical Examiners and the American Board of Psychiatry and Neurology, from which he has also received added qualifications in addiction psychiatry. He is a Distinquished Fellow of the American Psychiatric Association and is certified by the American Society of Addiction Medicine. He has written articles for numerous peer-reviewed publications, including the American Journal of Psychiatry, Archives of General Psychiatry, Biological Psychiatry, California Pediatrician and the Journal of Drug and Alcohol Dependence.
Dr. Wilkins earned his bachelor's degree from the University of Notre Dame and his medical degree from the University of California, San Diego (UCSD) School of Medicine. After studying neurology at Queen Square and St. Pancras Hospitals in London, he completed a medical internship at UCSD School of Medicine and a psychiatry residency at the University of California, Los Angeles.
Rasyidi Ernest, Wilkins Jeffery N, Danovitch Itai Training the next generation of providers in addiction medicine The Psychiatric clinics of North America, 2012; 35(2): 461-80.
Gorelick David A, Wilkins Jeffery N Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels Drug and alcohol dependence, 2006; 81(2): 189-95.
Does this profile need updating? Contact Us